Clorox (NYSE:CLX) PT Raised to $128.00

Clorox (NYSE:CLX) had its target price hoisted by investment analysts at UBS Group from $110.00 to $128.00 in a report issued on Friday, BenzingaRatingsTable reports. The firm currently has a “sell” rating on the stock. UBS Group’s target price would indicate a potential downside of 18.42% from the stock’s current price.

Several other research analysts have also issued reports on CLX. Bank of America restated a “neutral” rating and set a $154.00 price target (down previously from $165.00) on shares of Clorox in a report on Thursday, May 2nd. Royal Bank of Canada raised their price objective on shares of Clorox to $161.00 and gave the stock a “sector perform” rating in a research report on Friday. Citigroup set a $156.00 price objective on shares of Clorox and gave the stock a “hold” rating in a research report on Thursday, May 23rd. Wells Fargo & Co reaffirmed a “hold” rating and set a $153.00 price objective on shares of Clorox in a research report on Thursday. Finally, BMO Capital Markets set a $168.00 price objective on shares of Clorox and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. Clorox presently has an average rating of “Hold” and a consensus price target of $154.07.

Clorox stock traded up $0.76 during mid-day trading on Friday, hitting $156.90. 1,321,361 shares of the stock were exchanged, compared to its average volume of 971,180. The company has a quick ratio of 0.66, a current ratio of 0.91 and a debt-to-equity ratio of 4.09. Clorox has a 12 month low of $139.26 and a 12 month high of $167.70. The firm’s fifty day moving average price is $157.77. The firm has a market capitalization of $19.89 billion, a PE ratio of 24.83, a price-to-earnings-growth ratio of 4.57 and a beta of 0.36.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The firm had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. During the same quarter last year, the business earned $1.66 EPS. The company’s revenue was down 3.8% compared to the same quarter last year. On average, analysts forecast that Clorox will post 6.4 earnings per share for the current year.

In related news, SVP Denise Garner sold 20,399 shares of Clorox stock in a transaction on Friday, June 7th. The shares were sold at an average price of $157.61, for a total value of $3,215,086.39. Following the completion of the sale, the senior vice president now owns 4,896 shares of the company’s stock, valued at approximately $771,658.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.40% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Tower View Investment Management & Research LLC lifted its stake in Clorox by 19.4% during the 2nd quarter. Tower View Investment Management & Research LLC now owns 387 shares of the company’s stock valued at $59,000 after acquiring an additional 63 shares in the last quarter. World Asset Management Inc lifted its stake in Clorox by 0.7% during the 2nd quarter. World Asset Management Inc now owns 9,872 shares of the company’s stock valued at $1,512,000 after acquiring an additional 65 shares in the last quarter. Berman Capital Advisors LLC lifted its stake in Clorox by 25.6% during the 1st quarter. Berman Capital Advisors LLC now owns 353 shares of the company’s stock valued at $56,000 after acquiring an additional 72 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its stake in Clorox by 9.7% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 849 shares of the company’s stock valued at $136,000 after acquiring an additional 75 shares in the last quarter. Finally, Merit Financial Group LLC lifted its stake in Clorox by 5.4% during the 1st quarter. Merit Financial Group LLC now owns 1,473 shares of the company’s stock valued at $236,000 after acquiring an additional 75 shares in the last quarter. 76.92% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: What is meant by holder of record?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.